SB 436Session 114
Drugs, Prescription - As enacted, adds mandating the use of biosimilar drugs as a cost-saving measure the bureau of TennCare may implement; adds that a health carrier, health benefit plan, or utilization review organization may require a patient to try a biosimilar product prior to providing coverage for the equivalent branded prescription drug; requires the TennCare pharmacy advisory committee to consider as a factor the use of biosimilar drugs in the committee's recommendation to the bureau of TennCare on any drugs to be added to the state preferred drug list. - Amends TCA Title 4; Title 53; Title 56; Title 68 and Title 71.
Progress
- Introduced
- In committee
- Passed one chamber Not yet
- Passed legislature Not yet
- Sent to governor Not yet
- Became law Not yet
What this bill would cost
Fiscal notes are prepared by the state’s budget staff and reflect the bill as written at the time.
Votes
-
SENATE COMMERCE AND LABOR COMMITTEE: Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0 3/25/2025 Passed
9 yes0 no
Legislative history
-
House
Comp. became Pub. Ch. 206
-
Senate
Companion House Bill substituted
-
Senate
Placed on Senate Regular Calendar for 3/31/2025
-
Senate
Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0
-
Senate
Placed on Senate Commerce and Labor Committee calendar for 3/25/2025
-
Senate
Action deferred in Senate Commerce and Labor Committee to 3/25/2025
-
Senate
Placed on Senate Commerce and Labor Committee calendar for 3/18/2025
-
Senate
Placed on Senate Commerce and Labor Committee calendar for 3/18/2025
-
Senate
Passed on Second Consideration, refer to Senate Commerce and Labor Committee
-
Senate
Introduced, Passed on First Consideration
-
Senate
Filed for introduction